- ongoing, recruitingHuman Pharmacology (Phase I)- Other
A randomised, placebo-controlled, double-blinded, cross-over, Phase 1 study evaluating the safety and preliminary efficacy of the GLP 1 analogue ROSE-010 on appetite and food intake in overweight and obese subjects.
This study is testing a new medicine, ROSE-010, for people who are overweight or obese. It's a very early study looking at whether the medicine is safe and if it helps reduce appetite and how much food people eat.
Sweden - recruitingNA
Effects of Cranberry on Gut and Metabolic Health
This study looks at how cranberry drinks affect health in overweight people. We want to see if cranberries can help with blood sugar, fats, and gut bacteria. Participants will drink cranberry or a dummy drink for 12 weeks to see the effects.
Canada - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study to test whether BI 456906 (survodutide) influences the amount of bupropion, caffeine and midazolam in the blood in people with overweight or obesity
This study is looking at a new medicine called BI 456906. We want to see if it changes how your body handles other common medicines and substances like bupropion (an antidepressant), caffeine, and midazolam (a sedative). This is for people who are overweight or have obesity.
Belgium